MedPath

HEM Pharma Inc.

🇰🇷South Korea
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

HEM1036 Phase 2 Study in Low Anterior Resection Syndrome

Phase 2
Not yet recruiting
Conditions
LARS - Low Anterior Resection Syndrome
Interventions
First Posted Date
2022-09-02
Last Posted Date
2023-05-25
Lead Sponsor
HEM Pharma Inc.
Target Recruit Count
67
Registration Number
NCT05527301

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.